Cargando…

A Novel Submicron Emulsion System Loaded with Doxorubicin Overcome Multi-Drug Resistance in MCF-7/ADR Cells

The purpose of the present study was to develop the Solutol HS15-based doxorubicin submicron emulsion with good stability and overcoming multi-drug resistance. In this study, we prepared doxorubicin submicron emulsion, and examined the stability after autoclaving, the in vitro cytotoxic activity, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, W. P., Hua, H. Y., Sun, P. C., Zhao, Y. X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649786/ https://www.ncbi.nlm.nih.gov/pubmed/26664069

Ejemplares similares

Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride
por: Chen, Yuan-Yuan, et al.
Publicado: (2016)

Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
por: Miri, Ali, et al.
Publicado: (2023)

Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells
por: Liu, Ming, et al.
Publicado: (2016)

Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells
por: Jeon, Yong-Joon, et al.
Publicado: (2016)

The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo
por: Wang, Chao, et al.
Publicado: (2015)

Prenylflavonoid Isoxanthohumol Sensitizes MCF-7/ADR Cells to Doxorubicin Cytotoxicity via Acting as a Substrate of ABCB1
por: Liu, Ming, et al.
Publicado: (2017)

Cytotoxic and chemomodulatory effects of Phyllanthus niruri in MCF-7 and MCF-7(ADR) breast cancer cells
por: Abdel-Sattar, Ola E., et al.
Publicado: (2023)

Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity
por: Shi, Changcan, et al.
Publicado: (2020)

Gynecomastia: An ADR due to drug interaction
por: Aiman, Umme, et al.
Publicado: (2009)

CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy
por: Zhu, Z., et al.
Publicado: (2021)

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models
por: Li, Ying, et al.
Publicado: (2017)

Cholesterol Dependent Uptake and Interaction of Doxorubicin in MCF-7 Breast Cancer Cells
por: Weber, Petra, et al.
Publicado: (2013)

A Novel Electrochemical Differentiation between Exosomal-RNA of Breast Cancer MCF7 and MCF7/ADR-Resistant Cells
por: Abdelaziz, Mohammed H., et al.
Publicado: (2023)

PA‐MSHA inhibits the growth of doxorubicin‐resistant MCF‐7/ADR human breast cancer cells by downregulating Nrf2/p62
por: Wei, Yingze, et al.
Publicado: (2016)

Preparation and evaluation of poly(l-histidine) based pH-sensitive micelles for intracellular delivery of doxorubicin against MCF-7/ADR cells
por: Jia, Nan, et al.
Publicado: (2017)

Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin
por: Abdalla, Ashraf N., et al.
Publicado: (2021)

Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway
por: Shao, Wenna, et al.
Publicado: (2023)

Preparation of psoralen polymer–lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells
por: Huang, Qingqing, et al.
Publicado: (2018)

An injectable hybrid nanoparticle-in-oil-in-water submicron emulsion for improved delivery of poorly soluble drugs
por: Wang, Shuo, et al.
Publicado: (2012)

Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma
por: Zhang, Lu, et al.
Publicado: (2016)

Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier
por: Li, Jin-Ming, et al.
Publicado: (2015)

Enhanced delivery of PEAL nanoparticles with ultrasound targeted microbubble destruction mediated siRNA transfection in human MCF-7/S and MCF-7/ADR cells in vitro
por: Teng, Yanwei, et al.
Publicado: (2015)

Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1
por: Wang, Changyuan, et al.
Publicado: (2016)

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019)

Doxorubicin–Loaded Human Serum Albumin Submicron Particles: Preparation, Characterization and In Vitro Cellular Uptake
por: Chaiwaree, Saranya, et al.
Publicado: (2020)

Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1
por: Wei, Jinrong, et al.
Publicado: (2014)

Medical students as junior adverse drug event managers facilitating reporting of ADRs
por: Reumerman, Michael O., et al.
Publicado: (2021)

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2020)

In Vitro Cytotoxic Study of Euphorbia grantii Oliv. Aerial Parts against MCF-7 and MCF-7(ADR) Breast Cancer Cell Lines: A Bioactivity-Guided Isolation
por: Radi, Mai Hussin, et al.
Publicado: (2023)

Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells
por: Ku, Jin Mo, et al.
Publicado: (2015)

Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells
por: Guo, Baoqing, et al.
Publicado: (2016)

Discovery of IL-18 As a Novel Secreted Protein Contributing to Doxorubicin Resistance by Comparative Secretome Analysis of MCF-7 and MCF-7/Dox
por: Yao, Ling, et al.
Publicado: (2011)

Doxorubicin-conjugated dexamethasone induced MCF-7 apoptosis without entering the nucleus and able to overcome MDR-1-induced resistance
por: Chaikomon, Kamontip, et al.
Publicado: (2018)

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
por: Susa, Michiro, et al.
Publicado: (2009)

Surface Stiffness Has No Impact on MCF-7 Sensitivity to Doxorubicin
por: Šimoliūnas, Egidijus, et al.
Publicado: (2023)

The Reversal Effects of 3-Bromopyruvate on Multidrug Resistance In Vitro and In Vivo Derived from Human Breast MCF-7/ADR Cells
por: Wu, Long, et al.
Publicado: (2014)

Quantitative site- and structure-specific N-glycoproteomics characterization of differential N-glycosylation in MCF-7/ADR cancer stem cells
por: Xu, Feifei, et al.
Publicado: (2020)

Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway
por: Yang, Lin, et al.
Publicado: (2020)

Downregulation of eIF4G by microRNA-503 enhances drug sensitivity of MCF-7/ADR cells through suppressing the expression of ABC transport proteins
por: Pan, Xia, et al.
Publicado: (2017)

A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells
por: Wang, Liang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_isth37r3f0tm1hihg019f0bcks